최신 시험

EudraCT Number: 2004-004933-32

Sponsor Protocol Number: km 55/2004 – LORISTAH/CZ

Start Date: 2005-03-04

Sponsor Name: KRKA, d. d., Novo mesto

Full Title: Efficacy and safety of Lorista and Lorista H in the treatment of mild to moderate arterial hypertension

Medical condition: mild to moderate hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003734-34

Sponsor Protocol Number: BT0800BEL001

Start Date: 2005-03-03

Sponsor Name: Barrier Therapeutics nv

Full Title: A one-weel, randomized, double-blind, placebo-controlled pilot trial to evaluate oral R129160 (60 mg b.i.d.) on the alleviation of itch in atopic dermatitis patients

Medical condition: Atopic Dermatitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: BE (Ongoing) CZ (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-005012-80

Sponsor Protocol Number: S245.4007

Start Date: 2005-03-03

Sponsor Name: Solvay Pharmaceuticals GmbH

Full Title: Double-blind, multicenter, randomized, placebo-controlled, parallel-group study to investigate the effect of Creon 25 000 Minimicrospheres on body mass index (BMI) in patients after gastrectomy.

Medical condition: Patients atleast 18 years old with total or subtotal gastrektomy.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-002344-99

Sponsor Protocol Number: SKY0402-C-203

Start Date: 2005-03-03

Sponsor Name: SkyePharma, Inc.

Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Escalating/De-Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sustained-Release Encapsulated Bupivacaine (SKY0402) ...

Medical condition: Pain following bunionectomy

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.0		10006586		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004823-36

Sponsor Protocol Number: AZ1-2004

Start Date: 2005-03-03

Sponsor Name: daacro - diagnostic assessment and clinical research organization

Full Title: Effects of Alprazolam and Flupentixol on endocrine, autonomic and psychological parameters in the Trier Social Stress Test (TSST)

Medical condition: 69 healthy male subjects, age 18-45 undergo a laboratory stress test (TSST)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004392-11

Sponsor Protocol Number: ULg_GBM_04/1

Start Date: 2005-03-03

Sponsor Name: Centre Hospitalier Universitaire de Liege

Full Title: Human phase 1/2 clinical study of the safety and efficacy of sulfasalazine as a therapy for recurrent or progressing high grade gliomas.

Medical condition: Recurrent or progressive high grade glioma, including gliobastoma, anaplastic astrocytoma and oligo-astrocytoma.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-004928-12

Sponsor Protocol Number: VICER1

Start Date: 2005-03-03

Sponsor Name: INO Therapeutics AB

Full Title: A pilot, unicenter, prospective, aleatorized, with parallel groups, controlled and open to evaluate the efficacy of the Nitric Oxide for Inhalation in the prevention of reperfusion in pulmonary donor

Medical condition: pulmonary graft dysfunction

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-001332-23

Sponsor Protocol Number: EORTC Study 08013

Start Date: 2005-03-03

Sponsor Name: European Organisation for Research and Treatment of Cancer

Full Title: Phase II Study with Gefitinib (sequentially) following Gemcitabine/Cisplatin as induction regimen for patients with stage IIIA N2 NSCLC.

Medical condition: Advanced Non Small-Cell Lung Carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10061873		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2004-000167-95

Sponsor Protocol Number: Protocol F1J-MC-HMDI

Start Date: 2005-03-03

Sponsor Name: Eli Lilly and Company Limited

Full Title: Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Medical condition: Major Depressive Disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) IT (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2005-000127-42

Sponsor Protocol Number: NRSily1

Start Date: 2005-03-03

Sponsor Name: Medical University of Vienna

Full Title: Non Responder- STUDY: MULTICENTER STUDY TO EVALUATE THE EFFICACY OF SILYMARIN IN ADDITION TO COMBINATION-THERAPY WITH PEGYLATED INTERFERON ALFA 2A (PEG-IFN ALFA 2A) AND RIBAVIRIN IN PATIENTS WI...

Medical condition: HCV-patients, who have not responded to a previous therapy with INF or PEG-INF +/- Ribavirin.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: (No results available)

최신 시험

스폰서 및 공동 작업자

건강 상태

약물 개입